SCHEMBL2095353

SCHEMBL2095353

CC(CCC(N)=O)(c1ccccc1)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.53
ALDH1A1 P00352 1/20 0.53
ESR1 P03372 1/20 0.53
ESR2 Q92731 1/20 0.53
MAPT P10636 1/20 0.52
KMT2A Q03164 1/20 0.52
HIF1A Q16665 2/20 0.46
CYP2C19 P33261 1/20 0.46
CHEK1 O14757 1/20 0.45
FYN P06241 1/20 0.45
PDGFRB P09619 1/20 0.45
PIM1 P11309 1/20 0.45
FGFR1 P11362 1/20 0.45
FLT1 P17948 1/20 0.45
GRK5 P34947 1/20 0.45
MAP2K2 P36507 1/20 0.45
MAPK8 P45983 1/20 0.45
CDK8 P49336 1/20 0.45
RPS6KA3 P51812 1/20 0.45
PRKX P51817 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL75391 0.84 ALDH1A1 (0.72) CYP3A4ALDH1A1ESR1ESR2MAPT
SCHEMBL13865463 0.84 KIF11 (0.55) MAPTKMT2AKIF11HTT
SCHEMBL4581933 0.83 ESR1 (0.71) CYP3A4ALDH1A1ESR1ESR2HIF1A
SCHEMBL4055699 0.80 CYP2C19 (0.50) ALDH1A1MAPTKMT2AHIF1ACYP2C19
SCHEMBL362442 0.80 KMT2A (0.55) CYP3A4ALDH1A1ESR1ESR2MAPT
SCHEMBL1829559 0.79 MAPT (0.50) CYP3A4MAPTKMT2AHIF1ACYP2C19
SCHEMBL3399058 0.79 MAPT (0.46) CYP3A4ALDH1A1MAPTKMT2AHIF1A
SCHEMBL8521296 0.79 MAPT (0.46) ALDH1A1MAPTKMT2AHIF1ACYP2C19
SCHEMBL8698880 0.78 ALDH1A1 (0.50) CYP3A4ALDH1A1ESR1ESR2MAPT
SCHEMBL17064282 0.78 MAPT (0.44) ESR1ESR2MAPTKMT2AHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2350002-A1 NOVEL COMPOUNDS AS CALCIUM CHANNEL BLOCKERS Abbott Laboratories (US) 2011-08-03 EP claimed
US-8163761-B2 Methods and compositions for treating disorders HYDRA BIOSCIENCES, INC. (US) 2012-04-24 US disclosed
EP-2350002-A1 NOVEL COMPOUNDS AS CALCIUM CHANNEL BLOCKERS Abbott Laboratories (US) 2011-08-03 EP disclosed